Department of Medical Physiology, Division Heart & Lungs, University Medical Center Utrecht, Yalelaan 50, 3584 CM Utrecht, The Netherlands.
Europace. 2012 Mar;14(3):431-6. doi: 10.1093/europace/eur311. Epub 2011 Sep 22.
A number of predisposing factors have been suggested to be contributing to drug-induced torsade de pointes (TdP) arrhythmias: short-long-short (SLS) sequence, bradycardia, timing of drug administration, anaesthesia, ventricular remodelling, and altered ventricular activation due to ventricular ectopic beats (SLS) or idioventricular rhythm (IVR). Chronic atrio-ventricular (AV)-block (CAVB) dogs are susceptible to dofetilide-induced TdP.
In 32 anaesthetized animals, the relevance of ventricular remodelling for TdP susceptibility was studied by dofetilide [0.025 mg/kg/5 min intravenously (iv)] during bradycardia in the presence (CAVB, n= 18) or absence [acute atrio-ventricular block (AVB), n= 32] of ventricular remodelling. In sub-protocols, the possible pro-arrhythmic effects of timing of dofetilide administration: prior to (n= 11), or after creation of AVB (n= 9) and relevance of SLS pacing (n= 17) was investigated during IVR. Dofetilide was also given after AVB when the activation of the ventricles was normal: pacing (1000 ms) from the high septum (n= 7) or abnormal but fixed from the left ventricular apex (n= 5). Torsade de pointes inducibility was defined as reproducible (≥ 3 times) occurrence. In acute AV block (AAVB), dofetilide did not induce TdP spontaneously (0 of 32), whereas TdP was seen in 10 out of 18 serially tested dogs in CAVB (P< 0.001). The other factors: timing of dofetilide (0 of 11 vs. 0 of 9), SLS pacing (0 of 17 vs. 1 of 17), or ventricular activation (0 of 7 vs. 0 of 5) did not increase TdP susceptibility. Beat-to-beat variability of repolarization increased after ventricular remodelling and was highest prior to TdP induction.
In AAVB dogs, TdP is not spontaneously seen, whereas it is present in CAVB. This implies that ventricular remodelling is a prerequisite for TdP induction in this model.
许多诱发因素被认为与药物诱导的尖端扭转型室性心动过速(TdP)心律失常有关:短-长-短(SLS)序列、心动过缓、药物给药时间、麻醉、心室重构以及由于室性早搏(SLS)或室性自主节律(IVR)引起的心室激活改变。慢性房室(AV)阻滞(CAVB)犬易发生多非利特诱导的 TdP。
在 32 只麻醉动物中,通过在存在(CAVB,n=18)或不存在(急性房室阻滞(AVB),n=32)心室重构的情况下,静脉内给予多非利特[0.025mg/kg/5 分钟],研究心室重构对 TdP 易感性的相关性。在子方案中,研究了多非利特给药时间的可能致心律失常作用:在 AVB 之前(n=11)或之后(n=9)以及 SLS 起搏的相关性(n=17)在 IVR 期间进行研究。当心室激活正常时,在 AVB 后也给予多非利特:从高位间隔起搏(n=7)或从左心室心尖起搏(n=5)。TdP 可诱导性定义为可重现(≥3 次)发生。在急性 AV 阻滞(AAVB)中,多非利特不能自发诱导 TdP(32 例均未发生),而在 CAVB 中 18 例连续测试的犬中有 10 例出现 TdP(P<0.001)。其他因素:多非利特的给药时间(11 例均未发生与 9 例均未发生)、SLS 起搏(17 例均未发生与 17 例均发生)或心室激活(7 例均未发生与 5 例均发生)并未增加 TdP 易感性。心室重构后复极的逐搏变异性增加,在 TdP 诱导前最高。
在 AAVB 犬中,TdP 不会自发发生,而在 CAVB 中则会发生。这意味着心室重构是该模型中 TdP 诱导的先决条件。